Results 171 to 180 of about 19,704 (200)

Telmisartan in high-risk patients intolerant of ACE inhibitors

Lancet, The, 2009
Carl Heneghan
exaly   +2 more sources

Telmisartan

Reactions Weekly, 2003
openaire   +1 more source

Telmisartan

Reactions Weekly, 2022
openaire   +1 more source

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

Lancet, The, 2008
Roland E Schmieder, Janice Pogue, Leopoldo S. Piegas   +2 more
exaly  

Telmisartan

Drugs of the Future, 1997
M. Merlos, A. Casas, J. Castañer
openaire   +1 more source

Telmisartan

Reactions Weekly, 2018
openaire   +2 more sources

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

New England Journal of Medicine, 2008
Salim Yusuf, Koon K Teo, Janice Pogue
exaly  

Telmisartan

Reactions Weekly
openaire   +2 more sources

Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

New England Journal of Medicine, 2008
Salim Yusuf, Philip Bath, Jacques De Keyser   +2 more
exaly  

Telmisartan

Reactions Weekly, 2014
  +4 more sources